Investigational Drug Information for L-Citrulline
✉ Email this page to a colleague
What is the development status for investigational drug L-Citrulline?
L-Citrulline is an investigational drug.
There have been 34 clinical trials for L-Citrulline.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 20th 2021.
The most common disease conditions in clinical trials are Anemia, Sickle Cell, Hypertension, and Lung Injury. The leading clinical trial sponsors are Asklepion Pharmaceuticals, LLC, National Institutes of Health (NIH), and University of Mississippi Medical Center.
There are three hundred and ninety-one US patents protecting this investigational drug and fifteen international patents.
Summary for L-Citrulline
US Patents | 391 |
International Patents | 15,138 |
US Patent Applications | 5,019 |
WIPO Patent Applications | 0 |
Japanese Patent Applications | 37 |
Clinical Trial Progress | Phase 3 (2021-10-20) |
Vendors | 109 |
Recent Clinical Trials for L-Citrulline
Title | Sponsor | Phase |
---|---|---|
Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation | National Jewish Health | Phase 2 |
Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation | United States Department of Defense | Phase 2 |
Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation | University of Colorado, Denver | Phase 2 |
Clinical Trial Summary for L-Citrulline
Top disease conditions for L-Citrulline
Top clinical trial sponsors for L-Citrulline
US Patents for L-Citrulline
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
L-Citrulline | ⤷ Try a Trial | Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus | Seattle Genetics, Inc. (Bothell, WA) | ⤷ Try a Trial |
L-Citrulline | ⤷ Try a Trial | Methods of expressing products in mammalian cells | INTREXON CEU, INC. (Blacksburg, VA) | ⤷ Try a Trial |
L-Citrulline | ⤷ Try a Trial | Method of diagnosing and treating cancer using B-catenin splice variants | The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) | ⤷ Try a Trial |
L-Citrulline | ⤷ Try a Trial | Seaweed-derived cosmetic compositions | Skinergistics Clinical Skin Solutions Inc. (Vancouver, CA) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for L-Citrulline
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
L-Citrulline | Australia | AU2007345497 | 2027-01-29 | ⤷ Try a Trial |
L-Citrulline | Canada | CA2676865 | 2027-01-29 | ⤷ Try a Trial |
L-Citrulline | European Patent Office | EP2114986 | 2027-01-29 | ⤷ Try a Trial |
L-Citrulline | Spain | ES2425575 | 2027-01-29 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |